|
|
#1
08-12-2016, 04:25 AM
|
|||
|
|||
AstraZeneca wins UK cost approval for longer use of heart drug
AstraZeneca wins UK cost approval for longer use of heart drug
LONDON (Reuters) - Long term use of AstraZeneca's blood thinner Brilinta has been recommended as a cost-effective option for treating patients after a heart attack, Britain's healthcare cost watchdog NICE said on Friday. ??????? ??????: AstraZeneca wins UK cost approval for longer use of heart drug || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|
العرض الشجري